Key | % Net Assets |
---|---|
AstraZeneca | 5.6% |
Royal Bank of Scotland Group | 4.7% |
Rentokil Initial | 4.2% |
Morrison Supermarkets | 3.8% |
Other | 81.7% |
Name | % Net Assets |
---|---|
AstraZeneca | 5.6% |
Royal Bank of Scotland Group | 4.7% |
Rentokil Initial | 4.2% |
Morrison Supermarkets | 3.8% |
Barclays | 3.6% |
Lloyds Banking Group | 3.3% |
Vodafone Group | 3.2% |
Dixons Retail | 3.0% |
Resolution | 2.9% |
GlaxoSmithKline | 2.9% |
Key | % Net Assets |
---|---|
Consumer Services | 26.60% |
Financials | 25.20% |
Industrials | 15.80% |
Health Care | 10.10% |
Technology | 9.80% |
Date | 25-Apr-2024 |
---|---|
NAV | 27,250.00p |
Currency | GBP |
Change | -60.00p |
% | -0.22% |
YTD change | 10.00p |
YTD % | 0.04% |
Fund Inception | 05/05/1970 |
---|---|
Fund Manager | Kevin Murphy / Nick Kirrage |
TER | 1.52 (15-Jul-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.16 |
You are here: research